Protagonist Therapeutics

Protagonist Therapeutics financials

Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.

CreditSafe score

?

Score changed on Jan 30, 2023

Premium Content

Financial statements

USD	FY, 2016	FY, 2017	FY, 2018	FY, 2019	FY, 2020	FY, 2021
Revenue						27.4M
General and administrative expense	7.0M	11.8M	13.7M	15.7M	18.6M	27.2M
Operating expense total	32.7M	58.0M	73.2M	80.8M	93.1M
EBIT	(32.7M)	(37.9M)	(42.3M)	(80.5M)	(64.5M)	(125.8M)
Interest income	242.0K	940.0K	2.5M	2.8M	900.0K	443.0K
Pre tax profit			(39.7M)	(77.9M)	(64.8M)	(125.6M)
Income tax expense			(799.0K)	(700.0K)	1.3M
Net Income	(37.2M)	(37.0M)	(38.9M)	(77.2M)	(66.1M)	(125.6M)